Warby Parker Inc. (WRBY) Stock Analysis
Range Bound setup
Healthcare · Medical Instruments & Supplies
Sell if holding. At $24.50, A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 7.5%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4).
Warby Parker sells prescription eyewear, contact lenses, and vision care services through 323 retail stores and digital commerce, with unified pricing starting at $95 including prescription lenses. It employs ~4,000 people and operates two in-house optical labs. Contacts... Read more
Sell if holding. At $24.50, A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 7.5%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4). Chart setup: RSI 55 mid-range, Bollinger mid-band. Score 4.4/10, moderate confidence.
Passes 5/7 gates (clean insider activity, no SEC red flags, earnings proximity 78d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.
Recent Developments — Warby Parker Inc.
Latest news
- Reflecting On Beauty and Cosmetics Retailer Stocks’ Q4 Earnings: Warby Parker (NYSE:WRBY) - StockStory — StockStory neutral
- Warby Parker (WRBY) Q1 earnings report preview: What to look for - MSN — MSN neutral
- Warby Parker (WRBY) Q1 Earnings Report Preview: What To Look For - StockStory — StockStory neutral
- Reflecting on beauty and cosmetics retailer stocks’ Q4 earnings: Warby Parker (NYSE:WRBY) - MSN — MSN neutral
- How Warby Parker (WRBY) prepares for market disruptions | Q4 2025: Earnings Underperform - Revenue Report - Newser — Newser negative
Generated 2026-05-20T21:06:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
4 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. At $24.50, A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 7.5%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4). Chart setup: RSI 55 mid-range, Bollinger mid-band. Prior stop was $22.52. Score 4.4/10, moderate confidence.
Take-profit target: $26.03 (+7.5% upside). Prior stop was $22.52. Stop-loss: $22.52.
Thin upside margin: 7.5%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4); Weak overall score: 4.4/10.
Warby Parker Inc. trades at a P/E of 2551.0 (forward 37.9). TrendMatrix value score: 5.8/10. Verdict: Sell.
20 analysts cover WRBY with a consensus score of 4.0/5. Average price target: $30.
What does Warby Parker Inc. do?Warby Parker sells prescription eyewear, contact lenses, and vision care services through 323 retail stores and digital...
Warby Parker sells prescription eyewear, contact lenses, and vision care services through 323 retail stores and digital commerce, with unified pricing starting at $95 including prescription lenses. It employs ~4,000 people and operates two in-house optical labs. Contacts contributed 11.1% and eye exams 6.4% of 2025 net revenue, with glasses comprising the substantial majority.